Dr. Pereira has a BA in Physics from PUC-RJ, a M.S. in Biophysics from UFRJ, and a PhD in Biomedical Sciences/Human Genetics from the Mount Sinai Graduate School/City University of New York. In 1996 she joined the University of São Paulo at the Department of Genetics and Evolutionary Biology, where she established the first lines of murine ES cells and first knockout mice (model for Marfan syndrome) in Brazil, and in 2008 the first lines of human ES cells in the country. In 2019 she launched the DNA do Brasil Project, a population genomics initiative; and in 2021 she founded gen-t, a biotech leveraging the genomic diversity of the Brazilian population to foster R&I in the pharma industry. She is currently CEO of gen-t and Full Professor at the University of São Paulo.

Victor is CEO and Founder of Omica, a community of physicians, patients and researchers working together to build a new healthcare paradigm in Latin America. He is a bioengineer and designer working at the intersection of genomics and biodiversity.Victor previously served as CEO of MariMori Bioscience, a natural product discovery company, and as Vice President at Uncharted, a pioneer in smart cities infrastructure.

Dr. Maria Chatzou Dunford has over 15 years of experience in bioinformatics, biomedicine and developing the tools and platforms necessary to bring large-scale precision medicine projects to life globally. As a researcher at the Centre for Genomic Regulation in Barcelona, Maria designed tools and methods that facilitate the analysis of large-scale biomedical data and was part of the developing team of Nextflow, the programming framework which has revolutionised the computational analysis of genomic data Maria is a proactive and goal-oriented leader and an established industry expert in science-based solutions that propel genomics and personalised medicine forward, including HPC, Big Data, Cloud, and AI. A passionate entrepreneur, Dr. Chatzou Dunford has founded two companies: Innovation Forum Barcelona and Lifebit. Maria is a visionary in the field of bioinformatics and precision medicine, contributing to numerous consortia, high impact publications and international speaking engagements.

Matt is Lead Genomic Data Scientist for the Diverse Data Initiative within Genomics England. Genomics England’s Diverse Data Initiative aims to reduce health inequalities and improve patient outcomes in genomic medicine for minoritised communities in the UK. Matt’s previous academic work focused on epigenetic modifications in the early embryo and their potential role in mediating the effects of early life exposures on long-term health outcomes in a rural Gambian population. Matt holds honorary academic positions as a Senior Research Fellow in the Nutrition & Planetary Health Theme at the Medical Research Council Unit, The Gambia and as an Associate Professor in the Faculty of Epidemiology & Population Health at the London School of Hygiene and Tropical Medicine.